Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What key factors are powering the surge in the market right now?

The market for tissue heart valves has demonstrated consistent growth in the recent past. It is projected to increase from a net worth of $1.48 billion in 2024 to a value of $1.53 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.1%. Factors contributing to this growth during the historical phase include the rising incidence of lifestyle-related ailments, an increase in spending on healthcare, growth in the aged population, a surge in cardiac and pathological disorders, and an escalation in cases of heart diseases.

How fast Is the market expected to grow, and what’s its future value?

In the coming years, the tissue heart valves market is projected to experience a consistent growth, reaching a value of $1.70 billion in 2029 with a compound annual growth rate (CAGR) of 2.7%. The growth during the projected period can be credited to factors such as the increasing incidence of heart-related diseases, the emerging trend of sutureless procedures, the rise in the aging population, the upsurge in demand for cardiovascular treatments, and the expansion in healthcare investments. Key trends for the predicted period include advancements in technology, development of innovative culture systems, improvements in imaging technologies, progression in surgical techniques, and growth in emerging markets.

Get your market report here!

https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report

What main drivers are fueling expansion in the market?

The escalating rate of cardiovascular diseases is predicted to accelerate the expansion of the tissue heart valves market in the future. Cardiovascular diseases (CVDs) are a collection of disorders impacting the heart and blood vessels, which include conditions like heart attacks, strokes, and hypertension. The surge in cardiovascular diseases (CVDs) is mainly influenced by elements such as unhealthy habits, aging demographics, heightened prevalence of risk factors, inadequate diets, lack of physical activities, smoking, stress, and urbanization, all contributing to a higher incidence of heart-related disorders worldwide. The role of tissue heart valves is critical in managing cardiovascular diseases (CVDs) as they provide patients in need of valve replacement with a biocompatible, durable, and less thrombogenic solution, thereby enhancing long-term cardiac function and diminishing the possibility of complications. As mentioned in a report issued by the Heart Failure Society of America (HFSA), a professional company based in the US, in September 2024, roughly 6.7 million Americans aged 20 and above are presently contending with heart failure (HF), with the number expected to reach 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050 respectively. Therefore, the rising prevalence of cardiovascular diseases is propelling the tissue heart valve market’s growth.

What are the key segments defining the market?

The tissue heart valves market covered in this report is segmented –

1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves

2) By Valve Type: Aortic, Mitral, Tricuspid, Pulmonary

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves

2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp

Who are the key players steering the development of the market?

Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

What emerging trends are influencing the growth of the market?

Key players in the tissue heart valves market, like Medtronic plc., are focusing on creating innovative products like surgical aortic tissue valves to enhance the patient’s experience during implantation and to offer better lifetime patient management. A surgical aortic tissue valve is a biological tissue-based prosthetic heart valve, typically used to replace an impaired or diseased aortic valve during heart surgery. For example, in June 2024, Medtronic plc., a technology firm based in Ireland, unveiled the Avalus Ultra valve, a next-generation surgical aortic tissue valve. This product, developed based on a decade of clinical experience with the Avalus valve, is aimed at improving implantation ease and long-term patient care. The Avalus Ultra valve stands out because of its low profile, a base frame made of polyetheretherketone (PEEK) ensuring consistent circularity, and an unparalleled Effective Orifice Area (EOA) for better blood flow. Additionally, it consists of a radiopaque coil that makes future valve-in-valve procedures more apparent, ensuring prolonged durability for patients with aortic stenosis.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21302

Which regions are most influential in expanding the market?

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Hepatitis B Virus (HBV) Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report

Viral Hepatitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report

Hepatitis Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: